News and Publications

Patents, Litigation and ADR, News

Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict

Mar 8, 2018

Categories

Archive

Archives

News and Publications

Patents, Litigation and ADR, News

Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict

Mar 8, 2018